Alerts will be sent to your verified email
Verify Email
AARTIDRUGS
|
Aarti Drugs
|
Supriya Lifescience
|
Solara Active Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.9 % | 29.47 % | -8.31 % |
|
5yr Avg Net Profit Margin
|
8.4 % | 24.83 % | -5.56 % |
|
Price to Book
|
3.15 | 5.35 | 2.79 |
|
P/E
|
22.88 | 29.95 | 124.6 |
|
5yr Avg Cash Conversion Cycle
|
82.62 Days | 10.2 Days | 115.03 Days |
|
5yr Average Interest Coverage Ratio
|
9.51 | 36.33 | 0.55 |
|
5yr Avg ROCE
|
22.85 % | 37.03 % | 3.01 % |
|
5yr Avg Operating Profit Margin
|
14.52 % | 34.97 % | 10.34 % |
|
5 yr average Debt to Equity
|
0.49 | 0.17 | 0.69 |
|
5yr CAGR Net Profit
|
3.93 % | 10.17 % | n/a |
|
5yr Average Return on Assets
|
9.61 % | 18.81 % | -2.61 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.22 % | 68.3 % | 42.01 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 38.95 % |
|
Change in Promoter Holding (3 Yrs)
|
-4.76 % | 0.06 % | 1.61 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
7.17 % | -2.44 % | -1.56 % |
|
Aarti Drugs
|
Supriya Lifescience
|
Solara Active Pharma
|
|---|